Paid Clinical Trials Lakeland
Discover 1,571 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LutikizumabA Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
Sponsor:
AbbVie
Location:
Code:
NCT06257875
Conditions
Ulcerative Colitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lutikizumab Matching Placebo
Adalimumab Matching Placebo
Lutikizumab
Adalimumab
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Golazo®The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Sponsor:
Avantec Vascular
Location:
Code:
NCT06321575
Conditions
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)
GORE® VIABAHN® VBX vs. Bare Metal StentingThe GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Sponsor:
W.L.Gore & Associates
Location:
Code:
NCT05811364
Conditions
Aortoiliac Occlusive Disease
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent
BI 764524A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06321302
Conditions
Diabetic Retinopathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BI 764524
Sham comparator to BI 764524
Aflibercept (Eylea®) - US only
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Observational StudyCollection of Samples USOPTIVAL Study
Sponsor:
Universal Diagnostics
Location:
Code:
NCT04792684
Conditions
Colorectal Cancer (CRC)
Advanced Adenomas (AA)
Eligibility Criteria
Sex: All
Age: 45 - 70+
Healthy Volunteers: Accepted
Interventions
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Observational StudyPost-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Sponsor:
C. R. Bard
Location:
Code:
NCT04634916
Conditions
Kidney Disease, End-Stage
End-stage Renal Disease
Arteriovenous Fistula
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
EndoAVF Creation
Buccal Film vs. IV PalonosetronBuccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Sponsor:
Xiamen LP Pharmaceutical Co., Ltd
Location:
Code:
NCT05199818
Conditions
Chemotherapy-induced Nausea and Vomiting
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Palonosetron HCl Buccal Film 0.5 mg
IV Palonosetron 0.25 mg
Indigo® Aspiration SystemBOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
Sponsor:
Penumbra Inc.
Location:
Code:
NCT05003843
Conditions
Deep Vein Thrombosis
DVT
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Indigo Aspiration System
AzetukalnerA Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Sponsor:
Xenon Pharmaceuticals Inc.
Location:
Code:
NCT06775379
Conditions
Major Depressive Disorder
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Azetukalner
Placebo